{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T20:06:05Z","timestamp":1783800365763,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:00:00Z","timestamp":1701475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:00:00Z","timestamp":1701475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key science and technology project of Xinjiang Production and Construction Corps","award":["No. 2018AB022"],"award-info":[{"award-number":["No. 2018AB022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common chronic liver disease in China. Our study aimed to evaluate the screening value of the fatty liver index (FLI), hepatic steatosis index (HSI), lipid accumulation product (LAP), visceral adiposity index (VAI), and Zhejiang University index (ZJU), as well as other single indicators for MAFLD. We aimed to find the optimal screening tool and its appropriate cut-off values for rural Uyghur adults.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We completed a survey of 14,321 Uyghur adults in 51 groups in Kashgar, Xinjiang, in 2016 using a typical sampling method, with 12,794 patients ultimately included in statistical analyses. Fatty liver was diagnosed using ultrasonography.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of fatty liver disease (FLD) and MAFLD was 16.73% and 16.55%, respectively, and the FLI, HSI, LAP, VAI, and ZJU were all independently associated with an increased risk of MAFLD. The areas under the receiver operating characteristic curves (AUCs) of the FLI for diagnosing MAFLD in men and women were 0.853 and 0.847, respectively. The AUCs of the body mass index (BMI) for diagnosing MAFLD in men and women were 0.850 and 0.852, respectively. Compared with other metabolic-related markers, FLI had the largest AUC. In men, the optimal cut-off values of FLI and BMI for diagnosing MAFLD were 45 (sensitivity 84.83%, specificity 69.57%) and 27.4 (sensitivity 78.47%, specificity 76.30%), respectively. In women, the optimal cut-off values of FLI and BMI for diagnosing MAFLD were 45 (sensitivity 80.11%, specificity 74.23%) and 28.0 (sensitivity 79.56%, specificity 75.41%), respectively. In men and women, an FLI score of\u2009&lt;\u200930 ruled out MAFLD, while a score of\u2009\u2265\u200950 was a basis for diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>FLI and BMI had good screening ability for MAFLD and were superior to HSI, LAP, VAI, and ZJU in both sexes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01536-2","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T09:02:12Z","timestamp":1701507732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang"],"prefix":"10.1186","volume":"28","author":[{"given":"Yanbo","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,2]]},"reference":[{"issue":"1","key":"1536_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73 (1):202\u20139.","journal-title":"J Hepatol"},{"issue":"1","key":"1536_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64 (1):73\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"1536_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","volume":"103","author":"I Pierantonelli","year":"2019","unstructured":"Pierantonelli I, Svegliati-Baroni G. Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH. Transplantation. 2019;103 (1):e1\u201313.","journal-title":"Transplantation"},{"issue":"21","key":"1536_CR4","first-page":"177","volume":"2018","author":"National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association","year":"2018","unstructured":"National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. J Pract Hepatol. 2018;2018 (21):177\u201386.","journal-title":"J Pract Hepatol"},{"issue":"2","key":"1536_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jhep.2021.05.003","volume":"75","author":"Y Nan","year":"2021","unstructured":"Nan Y, An J, Bao J, Chen H, Chen Y, Ding H, et al. The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. J Hepatol. 2021;75 (2):454\u201361.","journal-title":"J Hepatol"},{"issue":"3","key":"1536_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/liv.14369","volume":"40","author":"J Zhang","year":"2020","unstructured":"Zhang J, Lin S, Jiang D, Li M, Chen Y, Li J, et al. Chronic hepatitis B and non-alcoholic fatty liver disease: conspirators or competitors? Liver Int. 2020;40 (3):496\u2013508.","journal-title":"Liver Int"},{"issue":"9","key":"1536_CR7","first-page":"577","volume":"40","author":"F Jiangao","year":"2020","unstructured":"Jiangao F, Jing Z. Epidemic status and harm of non alcoholic fatty liver disease. Chin J Dig. 2020;40 (9):577\u201380.","journal-title":"Chin J Dig"},{"issue":"01","key":"1536_CR8","first-page":"129","volume":"38","author":"D Shaojie","year":"2022","unstructured":"Shaojie D, Zunjing L, Jialiang C, Shukun Y. Value of lipid accumulation product and visceral fat index in predicting nonalcoholic fatty liver disease. J Clin Hepatol. 2022;38 (01):129\u201334.","journal-title":"J Clin Hepatol"},{"issue":"30","key":"1536_CR9","first-page":"3888","volume":"24","author":"G Xiaolian","year":"2021","unstructured":"Xiaolian G, Mingzhong X, Junxiu T, Yating A. Characteristics analysis of predictive models of nonalcoholic fatty liver disease. Chin Gen Pract. 2021;24 (30):3888\u201392, 99.","journal-title":"Chin Gen Pract."},{"key":"1536_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121890","author":"A Ismaiel","year":"2021","unstructured":"Ismaiel A, Jaaouani A, Leucuta DC, Popa SL, Dumitrascu DL. The visceral adiposity index in non-alcoholic fatty liver disease and liver fibrosis-systematic review and meta-analysis. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9121890.","journal-title":"Biomedicines."},{"issue":"9","key":"1536_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106723","volume":"9","author":"H Jia","year":"2014","unstructured":"Jia H, Shuxia G, Jiaming L, Mei Z, Yusong D. Ethnic differences in prevalence of general obesity and abdominal obesity among low-income rural Kazakh and Uyghur adults in far western China and implications in preventive public health. PLoS ONE. 2014;9 (9): e106723.","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"1536_CR12","first-page":"S4","volume":"35","author":"American Diabetes Association","year":"2012","unstructured":"American Diabetes Association. Executive summary: standards of medical care in diabetes\u20132012. Diabetes Care. 2012;35 (Suppl 1):S4\u201310.","journal-title":"Diabetes Care"},{"key":"1536_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"1536_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42 (7):503\u20138.","journal-title":"Dig Liver Dis"},{"key":"1536_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-230X-10-98","volume":"10","author":"G Bedogni","year":"2010","unstructured":"Bedogni G, Henry SK, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol. 2010;10:98.","journal-title":"BMC Gastroenterol"},{"key":"1536_CR16","doi-asserted-by":"publisher","first-page":"16494","DOI":"10.1038\/srep16494","volume":"5","author":"J Wang","year":"2015","unstructured":"Wang J, Xu C, Xun Y, Lu Z, Shi J, Yu C, et al. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015;5:16494.","journal-title":"Sci Rep"},{"issue":"4","key":"1536_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33 (4):920\u20132.","journal-title":"Diabetes Care"},{"issue":"12","key":"1536_CR18","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, Yoshinaga S, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 2020;40 (12):3018\u201330.","journal-title":"Liver Int"},{"key":"1536_CR19","first-page":"729","volume":"7","author":"WZ Chen","year":"2005","unstructured":"Chen WZ, Ni ZZ, Pan XP, Liu YY, Xia Y. Receiver operating characteristic curves to determine the optimal operating point and doubtable value interval. Mod Prevent Med. 2005;7:729\u201331.","journal-title":"Mod Prevent Med"},{"issue":"1","key":"1536_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12876-021-01782-w","volume":"21","author":"YL Chen","year":"2021","unstructured":"Chen YL, Li H, Li S, Xu Z, Tian S, Wu J, et al. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. BMC Gastroenterol. 2021;21 (1):212.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1536_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","volume":"70","author":"F Zhou","year":"2019","unstructured":"Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70 (4):1119\u201333.","journal-title":"Hepatology"},{"issue":"1","key":"1536_CR22","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1186\/s12889-021-11996-y","volume":"21","author":"WQ Wang","year":"2021","unstructured":"Wang WQ, Wei B, Song YP, Guo H, Zhang XH, Wang XP, et al. Metabolically healthy obesity and unhealthy normal weight rural adults in Xinjiang: prevalence and the associated factors. BMC Public Health. 2021;21 (1):1940.","journal-title":"BMC Public Health"},{"issue":"5","key":"1536_CR23","first-page":"539","volume":"36","author":"F Zhai","year":"2007","unstructured":"Zhai F, He Y, Wang Z, Hu Y. Status and characteristic of dietary intake of 12 minority nationalities in China. Wei Sheng Yan Jiu. 2007;36 (5):539\u201341.","journal-title":"Wei Sheng Yan Jiu"},{"issue":"07","key":"1536_CR24","first-page":"650","volume":"24","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhang L, He J, Yan Y. Relationship between blood pressure and obesity in adults of remote rural areas of Xinjiang. Chin J Hypertens. 2016;24 (07):650\u20136.","journal-title":"Chin J Hypertens"},{"issue":"12","key":"1536_CR25","first-page":"1164","volume":"34","author":"J He","year":"2013","unstructured":"He J, Guo H, Ding Y, Liu J, Zhang M, Ma R, et al. Epidemiological study on overweight and obesity among rural adult residents in Hazakh, Uygur and Han populations in Xinjiang. Chin J Epidemiol. 2013;34 (12):1164\u20138.","journal-title":"Chin J Epidemiol"},{"issue":"Suppl. 1","key":"1536_CR26","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1017\/S0007114500000982","volume":"83","author":"KN Frayn","year":"2000","unstructured":"Frayn KN. Visceral fat and insulin resistance: causative a correlative. Br J Nutr. 2000;83 (Suppl. 1):S71\u20137.","journal-title":"Br J Nutr"},{"key":"1536_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1172\/JCI118083","volume":"96","author":"N Abate","year":"1995","unstructured":"Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in man. J Clin Invest. 1995;96:88\u201398.","journal-title":"J Clin Invest"},{"issue":"9","key":"1536_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031420","volume":"9","author":"OO Olubamwo","year":"2019","unstructured":"Olubamwo OO, Virtanen JK, Pihlajamaki J, Mantyselka P, Tuomainen TP. Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort. BMJ Open. 2019;9 (9): e031420.","journal-title":"BMJ Open"},{"issue":"7","key":"1536_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026949","volume":"9","author":"OO Olubamwo","year":"2019","unstructured":"Olubamwo OO, Virtanen JK, Pihlajamaki J, Tuomainen TP. Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study. BMJ Open. 2019;9 (7): e026949.","journal-title":"BMJ Open"},{"issue":"14","key":"1536_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021430","volume":"10","author":"Y Higashiura","year":"2021","unstructured":"Higashiura Y, Furuhashi M, Tanaka M, Takahashi S, Mori K, Miyamori D, et al. Elevated fatty liver index is independently associated with new onset of hypertension during a 10-year period in both male and female subjects. J Am Heart Assoc. 2021;10 (14): e021430.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1536_CR31","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1038\/s41598-021-88025-w","volume":"11","author":"S Takahashi","year":"2021","unstructured":"Takahashi S, Tanaka M, Furuhashi M, Moniwa N, Koyama M, Higashiura Y, et al. Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects. Sci Rep. 2021;11 (1):8606.","journal-title":"Sci Rep"},{"key":"1536_CR32","doi-asserted-by":"publisher","first-page":"9941834","DOI":"10.1155\/2021\/9941834","volume":"2021","author":"H Ochiai","year":"2021","unstructured":"Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Sakamoto K, Azuma M, et al. Hepatic steatosis index and chronic kidney disease among middle-aged individuals: a large-scale study in Japan. Dis Markers. 2021;2021:9941834.","journal-title":"Dis Markers"},{"issue":"14","key":"1536_CR33","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.7150\/ijms.62010","volume":"18","author":"C Wang","year":"2021","unstructured":"Wang C, Cai Z, Deng X, Li H, Zhao Z, Guo C, et al. Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes. Int J Med Sci. 2021;18 (14):3280\u20139.","journal-title":"Int J Med Sci"},{"issue":"12","key":"1536_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3345\/kjp.2019.00248","volume":"62","author":"B Ozcabi","year":"2019","unstructured":"Ozcabi B, Demirhan S, Akyol M, Ozturkmen Akay H, Guven A. Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity. Korean J Pediatr. 2019;62 (12):450\u20135.","journal-title":"Korean J Pediatr"},{"issue":"2","key":"1536_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000450657","volume":"69","author":"M Zhang","year":"2016","unstructured":"Zhang M, Zheng L, Li P, Zhu Y, Chang H, Wang X, et al. 4-Year trajectory of visceral adiposity index in the development of type 2 diabetes: a prospective cohort study. Ann Nutr Metab. 2016;69 (2):142\u20139.","journal-title":"Ann Nutr Metab"},{"issue":"5","key":"1536_CR36","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00592-016-0878-5","volume":"53","author":"B Ji","year":"2016","unstructured":"Ji B, Qu H, Wang H, Wei H, Deng H. The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population. Acta Diabetol. 2016;53 (5):817\u201323.","journal-title":"Acta Diabetol"},{"issue":"9","key":"1536_CR37","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11 (9):1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1536_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120443","volume":"10","author":"BL Yang","year":"2015","unstructured":"Yang BL, Wu WC, Fang KC, Wang YC, Huo TI, Huang YH, et al. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLoS ONE. 2015;10 (3): e0120443.","journal-title":"PLoS ONE"},{"issue":"40","key":"1536_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001682","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore). 2015;94 (40): e1682.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"1536_CR40","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/j.1478-3231.2011.02580.x","volume":"31","author":"JH Kim","year":"2011","unstructured":"Kim JH, Kwon SY, Lee SW, Lee CH. Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population. Liver Int. 2011;31 (10):1600\u20131.","journal-title":"Liver Int"},{"issue":"1","key":"1536_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12876-018-0906-8","volume":"18","author":"FGBG Foschi","year":"2018","unstructured":"Foschi FGBG, Domenicali M, et al. Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study. BMC Gastroenterol. 2018;18 (1):177.","journal-title":"BMC Gastroenterol"},{"key":"1536_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11010132","author":"K Murayama","year":"2021","unstructured":"Murayama K, Okada M, Tanaka K, Inadomi C, Yoshioka W, Kubotsu Y, et al. Prediction of nonalcoholic fatty liver disease using noninvasive and non-imaging procedures in Japanese health checkup examinees. Diagnostics (Basel). 2021. https:\/\/doi.org\/10.3390\/diagnostics11010132.","journal-title":"Diagnostics (Basel)."},{"key":"1536_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12070664","author":"AL Han","year":"2022","unstructured":"Han AL, Lee HK. Comparison of the diagnostic performance of steatosis indices for discrimination of CT-diagnosed metabolic dysfunction-associated fatty liver disease. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12070664.","journal-title":"Metabolites"},{"key":"1536_CR44","unstructured":"National Bureau of statistics of the People's Republic of China. China Statistical Yearbook 2021. China Statistic Publishing House 2021. p. 31."},{"key":"1536_CR45","first-page":"607","volume":"42","author":"J Shi","year":"2021","unstructured":"Shi J, Su Q, Fan JG, Yang Z. Progress in drug treatment of metabolic associated fatty liver disease. Word Clin Drugs. 2021;42:607\u201311.","journal-title":"Word Clin Drugs"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01536-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01536-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01536-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T21:25:39Z","timestamp":1701552339000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01536-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,2]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1536"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01536-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,2]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethics Review Board (IERB) of the First Affiliated Hospital of Shihezi University School of Medicine (IERB no.: SHZ2010LL01). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"555"}}